Evidence map›Paper›PMID 42391498›Full record

ReviewInternational journal of geriatric psychiatry2026

England's Dementia Diagnosis Landscape: Strengths, Limitations, and Future Directions.

Jemma Hazan, Robert Howard, Jeremy D Isaacs

Abstract readReview
In one paragraph

Review in International journal of geriatric psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jemma HazanDivision of Psychiatry, University College London, London, UK.ORCID https://orcid.org/0000-0002-7223-4768
Robert HowardDivision of Psychiatry, University College London, London, UK.
Jeremy D IsaacsSt George's University Hospitals NHS Foundation Trust, London, UK.

Funding

Alzheimer's Research UK CRTF2023B-003Blood Biomarker ChallengeNational Institute for Health and Care Research
6 · The paper itself

Abstract

backgroundThe National Health Service (NHS) England Primary Care Dementia Data (PCDD) provides a comprehensive dementia registry, underpinning national policy to improve diagnosis, care, and support.

methodsThis paper evaluates the PCDD in comparison with international quality dementia registries (SveDem, NorCog, ADNeT).

resultsWe highlight strengths in PCDD coverage and case ascertainment, but also weaknesses in diagnostic specificity and post-diagnostic metrics.

conclusionsWe review currently collected metrics and discuss potential data expansions, including dementia severity and NICE-approved therapy uptake, alongside new targets, such as an 18-week standard for memory assessment service referrals.

Indexed as

DementiaRegistriesAgedEnglandHumansPrimary Health CareState Medicine

Identifiers

PMID42391498
PMCPMC13327468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.